Neurabin-II activators comprise a diverse array of chemicals that modulate the cellular functions of Neurabin-II by influencing specific signaling pathways. Among these, Calyculin A, a protein phosphatase inhibitor, indirectly activates Neurabin-II by sustaining phosphorylation events. Forskolin, a potent adenylate cyclase activator, enhances cAMP-PKA signaling, leading to the phosphorylation and activation of Neurabin-II. Staurosporine, a broad-spectrum kinase inhibitor, disrupts kinase activities, indirectly modulating Neurabin-II and its cellular functions. Additionally, the calcium ionophores A23187 and Ionomycin elevate intracellular calcium levels, activating Neurabin-II, which has been implicated in calcium-dependent processes.
Phorbol esters like PMA and TPA activate protein kinase C (PKC), influencing Neurabin-II through PKC-mediated phosphorylation. Furthermore, Rolipram, a PDE4 inhibitor, and Thapsigargin, a SERCA pump inhibitor, indirectly activate Neurabin-II by modulating cAMP levels and elevating cytosolic calcium, respectively. Bay K 8644, a dihydropyridine calcium channel activator, influences Neurabin-II through increased calcium influx. Prostaglandin E2 (PGE2), a lipid mediator, activates GPCRs, indirectly influencing Neurabin-II by modulating GPCR-associated signaling pathways. Collectively, these Neurabin-II activators provide a nuanced understanding of the intricate molecular mechanisms through which diverse chemicals can modulate Neurabin-II and contribute to the regulation of its cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to an increase in intracellular cAMP levels. Elevated cAMP levels can activate PKA, and studies suggest Neurabin-II may be phosphorylated by PKA. Forskolin, by enhancing cAMP-PKA signaling, may indirectly contribute to the activation of Neurabin-II and its associated cellular processes. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor. While not specific to Neurabin-II, its inhibition of various kinases can disrupt signaling pathways involved in Neurabin-II regulation. The intricate network of kinase activities affected by Staurosporine can indirectly modulate Neurabin-II, possibly altering its localization and interactions within the cell. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels. Neurabin-II has been implicated in calcium-dependent processes. A23187-induced elevation in cytosolic calcium can potentially activate Neurabin-II through calcium-dependent signaling pathways, influencing its cellular functions and interactions. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diester of phorbol and a potent activator of protein kinase C (PKC). Neurabin-II is known to be modulated by PKC-mediated phosphorylation. Therefore, PMA, by activating PKC, can potentially lead to the phosphorylation and activation of Neurabin-II, influencing its cellular dynamics. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), leading to an increase in intracellular cAMP levels. As cAMP-PKA signaling is implicated in Neurabin-II regulation, Rolipram can indirectly activate Neurabin-II by enhancing this pathway. The elevated cAMP levels can potentially modulate Neurabin-II phosphorylation and its functional interactions within the cell. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a specific inhibitor of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump, leading to an increase in cytosolic calcium levels. Neurabin-II has been associated with calcium-dependent signaling. Thapsigargin-induced elevation in cytosolic calcium can potentially activate Neurabin-II, influencing its cellular functions and interactions within specific signaling cascades. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K 8644 is a dihydropyridine calcium channel activator, leading to increased calcium influx. Neurabin-II has been linked to calcium-dependent processes. Bay K 8644-induced elevation in intracellular calcium levels can potentially activate Neurabin-II, influencing its cellular functions and interactions within specific signaling cascades associated with calcium signaling. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) is a lipid mediator that activates G protein-coupled receptors. Activation of specific GPCRs can lead to the modulation of intracellular signaling pathways, including those involving Neurabin-II. PGE2, by activating its cognate receptors, may indirectly influence Neurabin-II, potentially affecting its phosphorylation status and cellular functions within the context of GPCR-associated signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Neurabin-II has been implicated in calcium-dependent processes. Ionomycin-induced elevation in cytosolic calcium can potentially activate Neurabin-II through calcium-dependent signaling pathways, influencing its cellular functions and interactions within specific cascades associated with calcium signaling. | ||||||